Literature DB >> 18410370

A descriptive study on constructional impairment in frontotemporal dementia and Alzheimer's disease.

M Gasparini1, G Masciarelli, N Vanacore, D Ottaviani, E Salati, G Talarico, G L Lenzi, G Bruno.   

Abstract

BACKGROUND AND
PURPOSE: Frontotemporal dementia (FTD) is a degenerative disorder characterized, in its frontal variant, by psychiatric onset, deficits in executive functions and sparing of memory and visuo-spatial abilities. Studies on visuo-spatial abilities in FTD and Alzheimer's disease (AD) have mainly focused on constructional abilities (CA) and have yielded contrasting data, often depending either on the task used or biases in the clinical selection of patients. The aim of our study was to evaluate the frequency of the CA impairment in FTD-fv and AD patients at the early stage of the disease, and to verify if some distinctive features of this impairment can characterize each pathology.
METHODS: The copy-drawing task (Rey Complex Figure, RCF) of 41 patients with probable mild AD and 15 patients with probable mild FTD-fv were analysed by means of quantitative and qualitative indices.
RESULTS: Data showed that both AD and FTD patients displayed similar RCF scores, as well as execution strategies, type of errors and global analysis. The FTD group only had a significant deficit in the analysis of inner details.

Entities:  

Mesh:

Year:  2008        PMID: 18410370     DOI: 10.1111/j.1468-1331.2008.02128.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  2 in total

1.  Closing-in behaviour in fronto-temporal dementia.

Authors:  Elisabetta Ambron; Francesca Allaria; Robert D McIntosh; Sergio Della Sala
Journal:  J Neurol       Date:  2009-02-25       Impact factor: 4.849

2.  Distinct neuroanatomical substrates and cognitive mechanisms of figure copy performance in Alzheimer's disease and behavioral variant frontotemporal dementia.

Authors:  Katherine L Possin; Victor R Laluz; Oscar Z Alcantar; Bruce L Miller; Joel H Kramer
Journal:  Neuropsychologia       Date:  2010-10-26       Impact factor: 3.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.